On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannabisNewsBreaks – EVIO, Inc. (EVIO) Licensee Awarded Certification for Pesticide Analysis in Colorado

Company: EVIO, Inc. (EVIO)
Category: News

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced that its licensee, PhytaTech CO, has been awarded Certification for Pesticide Analysis in the State of Colorado. Per the update, PhytaTech received ISO 17025 certification, which is the highest recognized quality standard in the world for calibration and testing laboratories. “While pesticide testing is not state-mandated, we predict that it will be in the following months as the focus continues towards consumer safety and ensuring that products are clean and of the highest quality,” Stephen Goldman, laboratory director of PhytaTech, stated in the news release. “Pesticide residues are an extremely important public safety issue and something that has been plaguing the industry for years. EVIO remains committed to upholding the highest standards of the testing process and instilling consumer confidence in this expanding industry.” PhytaTech is now accepting both medical and retail marijuana flower and trim samples from licensed medical and retail marijuana businesses for optional pesticide testing until mandatory testing initiates.

To view the full press release, visit http://cnw.fm/tDvm8

About EVIO, Inc.

EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The company’s EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. The company’s EVIO Biosciences Division is dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoid system. For more information, visit the company’s website at www.EvioLabs.com

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Contact us: 303.498.7722